Role of garlic extract and silymarin compared to dimercaptosuccinic acid (DMSA) in treatment of lead induced nephropathy in adult male albino rats  by El-Khishin, Iman A. et al.
Toxicology Reports 2 (2015) 824–832
Contents lists available at ScienceDirect
Toxicology  Reports
j ourna l h o mepa ge: www.elsev ier .com/ locate / toxrep
Role  of  garlic  extract  and  silymarin  compared  to
dimercaptosuccinic  acid  (DMSA)  in  treatment  of  lead  induced
nephropathy  in  adult  male  albino  rats
Iman  A.  El-Khishin1,  Yara  Mohamed  Medhat  El-fakharany2,
Omaima  I. Abdel  Hamid ∗
Forensic Medicine and Clinical Toxicology Department, Faculty of Medicine, Zagazig University, Egypt
a  r  t  i c  l  e  i  n  f  o
Article history:
Received 4 January 2015
Received in revised form 28 April 2015
Accepted 28 April 2015
Available online 8 May 2015
Chemical compounds studied in this article:
Lead-acetate (PubChem CID: 19878658)
DMSA (PubChem CID: 2724354)
Garlic (PubChem CID: 6850761)
Silymarin (PubChem CID: 1548994)
Keywords:
a  b  s  t  r  a  c  t
Lead  poisoning  has  been  known  as  an  important  disorder  that  affects  individuals  through
acute, sub-acute  and  chronic  exposure  in  environmental  and occupational  settings.  This
study was  conducted  to compare  the  curative  role of garlic  combined  with  silymarin  versus
dimercaptosuccinic  acid  (DMSA)  in decreasing  lead induced  nephrotoxicity  in  adult  male
albino rats.  The  period  of lead  intoxication  extended  for 3 months  followed  by either  1
month  treatment  with  garlic  and  silymarin  or 5  days  treatment  with  DMSA.  Lead  poison-
ing caused  non-signiﬁcant  difference  in  kidney  function  tests  (BUN  and  serum  creatinine)
while,  it  caused  signiﬁcant  elevation  in  kidney  lead  level,  signiﬁcant  decrease  in renal
antioxidant  enzyme  glutathione  peroxidase  and  signiﬁcant  elevation  in  kidney  malon-
dialdehyde.  Histologically,  lead  induced  disorganization  and  shrinkage  of  glomeruli  with
sloughing  and  vaculation  of  epithelium,  widening  of  Bowman’s  space  and  inﬂammatory
inﬁltration  in renal  medulla.  Treatment  by  garlic  extract  combined  with  silymarin  as  wellLead poisoning
Garlic
Silymarin
DMSA
Kidney
as  treatment  with  DMSA  resulted  in signiﬁcant  improvement  in  the  affected  parameters.
Also,  both  methods  of  treatment  resulted  in improvement  of  the  histopathological  changes.
It can be concluded  that  garlic  extract  combined  to silymarin  is  comparable  to  DMSA  in
amelioration  of lead  induced  nephrotoxicity.
©  2015  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is  an  open  access  article  under
the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. IntroductionLead (Pb) toxicity is probably the most common form of
heavy metal intoxication. It is well-documented as one of
the most dangerous and insidious poisons [1]. Chronic lead
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2214-7500/© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open ac
licenses/by-nc-nd/4.0/).poisoning is responsible for renal failure in experimental
animals [2].
The currently approved treatment for lead poisoning is
to administer chelating agents that form an insoluble com-
plex with lead and remove it from lead burdened tissue [3].
Meso-2,3-dimercaptosuccinic acid (DMSA) is a sulfhydryl-
containing, water-soluble, metal chelator. It is non-toxic
and administered orally. It has been in use as an antidote
to heavy metal toxicity since the 1950s. Recent clinical use
and research establishes this compound as the premier
metal chelation compound, based on oral dosing, urinary
excretion, and its safety characteristics compared to other
chelating substances [4].
cess article under the CC BY-NC-ND license (http://creativecommons.org/
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A positive correlation has been established between
ietary supplementation with certain vegetables and
lants and the reduction of toxic effects of various toxicants
nd environmental agents, including heavy metals [5].
Garlic is one of the plants necessary in everyday life from
he past until now. It contains active compounds that are
esponsible for its effect on almost every part of the human
ody. Garlic is considered an excellent tonic for the human.
t has antioxidant, anti-thrombotic, hypo-cholesterolemic
nd anti-hypertensive properties [6]. The bulb of the plant
as been used as a carminative, anti-septic, expectorant,
nti-helmintic and diuretic [7]. Sulfur-containing amino
cids like, cysteine in garlic have already been reported for
heir chemo-prophylactic use in lead poisoning [8].
Silymarin is a drug that has been used for many years
n alternate and modern medicine for treating hepatic
iseases. Its antioxidant, anti-inﬂammatory and anti-
poptotic effects make it an interesting herbal medicine,
nd these properties have implicated this compound as a
otential reno-protective agent [9]. Because of the antiox-
dant activity and radical scavenging effect of silymarin,
t has cyto-protection activities. The mechanisms of sily-
arin protection are most probably due to blockade and
djustment of cell transporters, P-glycoprotein, estrogenic
nd nuclear receptors [10].
The aim of this study was to compare the role of a com-
ination of garlic extract and silymarin versus DMSA in
ecreasing lead induced nephropathy in adult albino rats.
. Materials and methods
This study is a part of a research project funded by the
roject Management of Zagazig University.
.1. Chemicals
1) Lead-acetate [(C2H3O2)2Pb]: Lead acetate in the form of
white crystals manufactured by El Nasr Pharmaceutical
Chemical Company – Cairo – Egypt.
2) DMSA: obtained from Sigma–Aldrich Chemical Com-
pany – Cairo – Egypt.
3) Aqueous garlic extract was prepared at Department of
Pharmacognosy, Faculty of Pharmacy – Zagazig Univer-
sity – Egypt.
4) Silymarin: extraction of silymarin from milk thistle
plant was carried out at Department of Pharmacognosy,
Faculty of Medicine – Zagazig University – Egypt.
.2. Animals
Seventy adult male albino rats of average weight
etween 180 and 200 g were obtained from the animal
ouse of Faculty of Medicine, Zagazig University. Before
ommencing experimentation, the animals were subjected
o 10 days period of passive prelimination in order to adapt
hemselves to their new environment, to ascertain their
hysical wellbeing and to exclude diseased animals. Food
as offered in equal amounts to all rats in each cage, water
as offered in separate clean containers.
The present study was conducted in accordance with
he international guidelines for animal research and aftereports 2 (2015) 824–832 825
the approval of the Institutional Review Board on animal
research at Faculty of Medicine – Zagazig University – Egypt
(study number 2009/16-3-2014).
2.3. Study protocol
Rats were randomly divided into seven experimental
groups:
Group I (negative
control group): 10 rats received water and food to
measure the basic parameters for 4
months.
Group II (positive
control group): 10 rats, each rat received 1 ml
saline orally per day 6 days/week
for 4 months.
Group III (GS): 10 rats, each received 20 mg/kg/
day of garlic in 1 ml  saline [11] and
silymarin 1000 mg/kg/day (1/10
LD50) in 1 ml  saline [12] orally by
gavage 6 days/week for 1 month.
Group IV (DMSA): 10 rats, each received DMSA in
a dose of 30 mg/kg (therapeutic
dose) dissolved in 1 ml  saline once
daily orally by gavage for 5 days
[13].
Group V (Pb): 10 rats, each received lead acetate
in a dose of 20 mg/kg/day orally
in 1 ml  saline 6 days/week for 3
months [14].
Group VI (Pb–GS): 10 rats, each received Pb acetate
for 3 months followed by 20 mg/kg/
day of garlic in 1 ml  saline and
1000 mg/kg/day of silymarin in
1 ml  saline for another 1 month.
Group VII
(Pb–DMSA): 10 rats, each received Pb acetate
for 3 months followed by 30 mg/kg/
day DMSA dissolved in 1 ml  saline
for ﬁve days.
2.4. Methods
2.4.1. Plant material
The experimental plants (garlic and Silybum marianum)
were collected from Al-Kasassin Experimental Farm, Horti-
culture Research Station, Ismailia Governorate and the soil
was sandy and the plants were irrigated from AL-Abbasah
canal which is a branch from Nile water.
2.4.2. Preparation of the plant extract
Garlic and silymarin extracts were freshly prepared
weekly• Garlic: 200 mg  of fresh peeled garlic cloves were
weighted by sensitive balance then homogenized with
10 ml of distillated water to prepare a concentration of
20 mg/ml. The homogenate was centrifuged at 3000 × g
826 I.A. El-Khishin et al. / Toxicology RFig. 1. GC–MS chromatograph of garlic extract.
for 10 min  to remove particulate matter and the super-
natant fraction was used for the experiment [11].
• Silymarin: ﬁne powder of seeds of milk thistle was made
in a blender. Defatting the seed powder of Silybum mari-
anum in n-hexane 2–3 times and extracted with aqueous
acetone. The extract was concentrated to remove ace-
tone by using a rotary evaporator, and then washed by
hexane again to remove hydrophobic impurities. The
remaining concentrate was treated with 1% NaCl solution
to remove water soluble impurities. The precipitate and
solid obtained through drying were combined together
to form crude silymarin. The crude silymarin was washed
with aqueous ethanol and then dried completely to give
the reﬁned silymarin [15].
Then gas chromatography–mass spectrometry
(GC–MS) analysis of the extracts was performed. The
Chromatographic column used was TR. 35 MS  column
(30 m × 0.25 mm × 0.25 m).  Helium was used as carrier
gas at a ﬂow of 1.5 ml/min. Temperature programming:
the column temperature was maintained at 50 ◦C for
1 min, and then raised to 280 ◦C with a rate of 20 ◦C/min.
The mass spectrometer was operated in electron impact
(EI) ionization mode with electron energy of 70 eV and
temperature 280 ◦C. The transfer line temperature was
200 ◦C and the programmed temperature variance was
splitless. Mass list range was 50–500 amu  (Fig. 1).
2.4.3. Biochemical study
Twenty-four hours after the end of treatment in each
group animals were sacriﬁced and venous blood samples
were obtained from the retro-orbital plexus of anaes-
thetized animals, the blood was left for spontaneous
coagulation and serum was separated for estimation of kid-
ney function tests (blood urea nitrogen (BUN) and serum
creatinine) using Biomerieux France kit by enzymatic col-
orimetic method [16].
2.4.4. Kidney examination
After sacriﬁce, both kidneys of each rat were dividedinto parts, one part weighed 500 mg  was wrapped with alu-
minum foil and embedded in liquid nitrogen for 1 h then
kept frozen in −80 ◦C till used to asses lead concentra-
tion in tissues by the graphite furnace atomic absorptioneports 2 (2015) 824–832
spectrophotometry [17]. Another part was  ﬁxed in 10%
formalin saline solution for histopathological examination
after staining with haematoxylin and eosin according to
Bancroft and Stevens [18].
Part of renal tissue was perfused in 0.9% NaCl contain-
ing 0.16 mg/ml  heparin. Tissue was washed and minced
in ice-cold 0.25 M sucrose, then homogenized, diluted and
centrifuged at 4000 × g and 4 ◦C for 2 min. The supernatant
was  used to measure glutathione peroxidase (GPX) activity
following Paglia and Valentine according to the pamphlet
of Bio-diagnostic kits using calorimetric method [19].
Renal tissue was perfused with a phosphate buffered
saline solution, pH 7.4 containing 0.16 mg/ml  heparin to
remove any red blood cells and clots, homogenized in
5–10 ml  cold buffered per gram tissue then centrifuged at
4000 × g for 15 min. The supernatant is used for measur-
ing malondialdehyde (MDA) using Bio-diagnostic kits of
colorimetric method according to Satoh [20].
The collected data of kidney function tests, kidney lead
level and renal antioxidant parameters were expressed as
mean ± SD. The statistical analysis was done using ANOVA
and student’s t tests of Epi-info statistical package pro-
gram version 6.04d, January 2001. Correlation coefﬁcient
was  done by Excel-Ofﬁce 2007.
3. Results
3.1. Death rate
Two  rats died in group V (Pb), one rat in group VI (Pb–GS)
and one rat in group VII (Pb–DMSA).
3.2. Biochemical results
As shown in Table 1, there were no signiﬁcant dif-
ferences in all of the measured parameters {the kidney
function tests (BUN and serum creatinine), kidney lead
level and renal antioxidant parameters (GPX & MDA)}
among control groups I (negative control), II (positive con-
trol), III (GS) and IV (DMSA) so the values of group II
(positive control) was  used for comparison with other
groups of the study (P > 0.05).
3.3. Kidney function tests (BUN, serum creatinine)
There was  no signiﬁcant difference in the kidney func-
tion tests (BUN and serum creatinine) among groups II
(positive control), V (Pb), VI (Pb–GS) and VII (Pb–DMSA)
by (ANOVA) study (Table 2).
3.4. Kidney lead level results
Table 2 shows a signiﬁcant difference in kidney lead
level among groups II (positive control), V (Pb), VI (Pb–GS)
and VII (Pb–DMSA) by (ANOVA) study (P < 0.05).
The Least signiﬁcant difference in Table 3 revealed that
kidney lead level in group II (positive control group) is sig-
niﬁcantly lower than that of group V (Pb), VI (Pb–GS) and
VII (Pb–DMSA), also there was a signiﬁcant reduction in
kidney lead level after treatment with both garlic and sily-
marin (group VI) and DMSA (group VII) while there was  a
I.A. El-Khishin et al. / Toxicology Reports 2 (2015) 824–832 827
Table  1
Statistical comparison between groups I (negative control), II (positive control), III (GS) and IV (DMSA) regarding kidney function tests (BUN, serum
creatinine), kidney lead level and renal antioxidant parameters (GPX&MDA) by ANOVA test.
Parameter Group F P
Negative control group
(I)
n  = 10
Positive control group
(II)
n = 10
GS group (III)
n  = 10
DMSA group (IV)
n  = 10
Mean ± SD
BUN (mg/dl) 27.2 ± 3.31 27.14 ± 3.28 26.79 ± 2.59 27.3 ± 3.16 0.047 0.986#
Creatinine (mg/dl) 0.93 ± 0.21 0.95 ± 0.19 0.94 ± 0.18 0.94 ± 0.20 0.025 0.995#
Kidney lead level (g/g tissue) 0.891 ± 0.041 0.887 ± 0.049 0.884 ± 0.050 0.856 ± 0.088 0.696 0.560#
Renal GPX (/g tissue) 0.491 ± 0.053 0.464 ± 0.041 0.496 ± 0.049 0.461 ± 0.049 1.380 0.265#
Renal MDA  (nmol/g tissue) 0.484 ± 0.046 0.464 ± 0.041 0.481 ± 0.045 0.514 ± 0.049 2.042 0.125#
# Non-signiﬁcance (P > 0.05 – ANOVA).
SD: standard deviation.
n  = number of rats in each group.
Table 2
Statistical comparison between group II (positive control), group V (Pb), group VI (Pb–GS) and group VII (Pb–DMSA) regarding kidney function tests (BUN,
serum  creatinine), kidney lead level and renal antioxidant parameters (GPX&MDA) by ANOVA test.
Parameter Group F P
Positive control group
(II)
n = 10
Pb group (V)
n  = 8
Pb and GS (VI)
n  = 9
Pb and DMSA (VII)
n  = 9
Mean ± SD
BUN (mg/dl) 27.14 ± 3.28 29.95 ± 3.12 30.08 ± 3.61 29.92 ± 3.46 1.780 0.168#
Creatinine (mg/dl) 0.955 ± 0.193 0.941 ± 0.191 0.919 ± 0.180 0.956 ± 0.179 0.086 0.967#
Kidney lead level (g/g tissue) 0.887 ± 0.049 21.45 ± 3.857 8.869 ± 1.748 8.294 ± 2.133 129.412 0.000*
GPX (/g tissue) 0.464 ± 0.041 0.190 ± 0.037 0.363 ± 0.074 0.401 ± 0.121 23.420 0.000*
MDA  (nmol/g tissue) 0.464 ± 0.041 2.011 ± 0.412 0.285 ± 0.056 0.240 ± 0.052 155.145 0.000*
# Non-signiﬁcance (P > 0.05 – ANOVA).
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LD: standard deviation.
 = number of rats in each group.
* Signiﬁcance (P < 0.05 – ANOVA).
on-signiﬁcant difference between group VI (Pb–GS) and
roup VII (Pb–DMSA).
.5. Renal anti-oxidant parameters
In Table 2, there was a signiﬁcant difference in (GPX)
nd (MDA) among groups II (positive control), V (Pb), VI
Pb–GS) and VII (Pb–DMSA) by (ANOVA) study (P < 0.05).The least signiﬁcant difference for GPX revealed that
here was a signiﬁcant decrease in GPX in lead treated
roup (Pb) when compared to the positive control group
hile treatment with both garlic combined with silymarin
able 3
east signiﬁcant difference between group II (positive control), group V (Pb), VI (P
Kidney lead level (g/g tissue) Group
Positive Control group (II)
n = 10
Pb grou
n  = 8
0.887 ± 0.049 21.45 ±
Positive control group (II) – 0.000*
Pb group (V) – – 
Pb & GS group (VI) – – 
* Signiﬁcance (P < 0.05 – t-test). n: number of rats in each group.
# Non-signiﬁcance (P > 0.05 – t-test). SD: standard deviation.(Pb–GS) and DMSA (Pb–DMSA) caused signiﬁcant elevation
in GPX when compared to lead treated group. There was
non-signiﬁcant difference when comparing DMSA treated
group (Pb–DMSA) to positive control group and garlic and
silymarin treated group (Pb–GS) while still there was a sig-
niﬁcant difference between (Pb–GS) and positive control
group (Table 4).
Table 5 showed that the least signiﬁcant difference for
MDA  revealed a signiﬁcant elevation in lead group (Pb)
when compared to the positive control group. Treatment
with combined garlic and silymarin (Pb–GS) and DMSA
(Pb–DMSA) caused signiﬁcant decrease in MDA  when
b–GS) and VII (Pb–DMSA) regarding kidney lead level.
p (V) Pb and GS group (VI)
n = 9
Pb and DMSA (VII)
n  = 9
Mean ± SD
 3.857 8.869 ± 1.748 8.294 ± 2.133
0.000* 0.000*
0.000* 0.000*
– 0.591#
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Table 4
Least signiﬁcant difference between groups II (positive control), V (Pb), VI (Pb–GS) and VII (Pb–DMSA) regarding renal glutathione peroxidase (GPX).
GPX (/gm tissue) Group
Positive control group (II)
n  = 10
Pb group (V)
n  = 8
Pb and GS group (VI)
n = 9
Pb and DMSA group (VII)
n = 9
Mean ± SD
(0.464 ± 0.041) (0.190 ± 0.037) (0.363 ± 0.074) (0.401 ± 0.121)
Positive control group (II) – 0.000* 0.006* 0.074#
Pb group (V) – – 0.000* 0.000*
Pb and GS (VI) – – – 0.275#
* Signiﬁcance (P < 0.05 – t-test). n = number of rats in each group.
SD:  standard deviation.
# Non-signiﬁcance (P > 0.05 – ANOVA).
Table 5
Least signiﬁcant difference between groups II (positive control), V (Pb), VI (Pb–GS) and VII (Pb–DMSA) regarding renal malondialdehyde (MDA).
MDA (nmol/g tissue) Group
Positive control group (II)
n  = 10
Pb group (V)
n  = 8
Pb and GS group (VI)
n = 9
Pb and DMSA group (VII)
n = 9
Mean ± SD
0.464 ± 0.041 2.011 ± 0.412 0.285 ± 0.056 0.240 ± 0.052
Positive control group (II) – 0.000* 0.069# 0.029#
Pb group (V) – – 0.000* 0.000*
#
.Pb and GS (VI) – – 
* Signiﬁcance (P < 0.05 – t-test). SD: standard deviation.
# Non-signiﬁcance (P > 0.05 – ANOVA). n = number of rats in each group
compared to lead treated group to reach a non-signiﬁcant
change when compared to the positive control group. There
was a non-signiﬁcant difference when comparing (Pb–GS)
and (Pb–DMSA).
There was a strong negative correlation between kid-
ney lead level and GPX and a strong positive correlation
between kidney lead level and MDA  (Table 6).
3.6. Histo-pathological observations
Group I (negative control), II (positive control group),
III (GS) and IV (DMSA) showed the normal kidney struc-
ture. The cortex showed normal renal corpuscles formed
of a tuft of capillaries (glomerulus) surrounded by nar-
row Bowman’s space, renal convoluted tubules are lined
by cuboidal epithelium. The proximal tubules have narrow
Lumina while distal tubules show wide Lumina (Fig. 2A and
B).
Lead treated group (V) showed disorganization of the
glomeruli with sloughing of the epithelium and a widening
of Bowman’s space (Fig. 3A). The glomerular epithelium
Table 6
Correlation co-efﬁcient between kidney lead level and oxidative stress
parameters (glutathione peroxidase (GPX) and malondialdehyde (MDA)
using Pearson correlation.
Kidney lead level
r p
GPX −0.731 0.000**
MDA 0.825 0.000**
** Strong correlation.– 0.649
showed vaculation and some glomeruli showed shrinkage
(Fig. 3B). There was inﬂammatory inﬁltration in the renal
medulla (Fig. 3C).
Treatment with garlic and silymarin in group (VI)
resulted in improvement in the histopathological changes
and recovery of some glomeruli (Fig. 4A) and decrease in
the inﬂammatory inﬁltration in the medulla (Fig. 4B).
Also treatment with DMSA in group (VII) has resulted
in improvement in the histopathological changes. There
was  slight congestion and widening of Bowman’s space
(Fig. 5A). The tubules were normally lined by cuboidal
epithelium with minimal inﬂammatory inﬁltration
(Fig. 5B).
4. Discussion
Lead is a common environmental pollutant known to
induce chronic renal disease as urinary elimination is the
main route of lead excretion [21].
In the present study lead acetate administered to rats
in a dose of 20 mg/kg/day for 3 months produced a signif-
icant elevation of kidney lead level, a signiﬁcant decrease
in GPX and signiﬁcant increase in MDA  when compared to
the positive control group. The absorbed Pb is conjugated in
the liver and passed to the kidney, where a small quantity is
excreted in urine and the rest accumulates in various body
organs and affects many biological activities at the molec-
ular, cellular and intracellular levels and this explains the
cause of signiﬁcant elevation of kidney lead level in lead
treated rats [22].
The decreased activity of GPX due to lead exposure was
reported in both human [23], and animal studies [24];
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Fig. 2. (A) A photomicrograph of a section in a control rat’s kidney show-
ing normal glomerulus surrounded by narrow Bowman’s space (G), renal
convoluted tubules lined with cuboidal epithelium (C). The proximal
tubules have narrow lumina (N) while distal tubules show wide lumina
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Fig. 3. (A) A photomicrograph of a section in rat’s kidney of the lead
treated group (V) showing disorganization with sloughing of the epithe-
lium of the glomeruli (E) and widening of Bowman’s spaces (W)  (H&E
×400). (B) A photomicrograph of a section in the renal cortex of a lead
treated rat (group V) showing vaculation of the glomerular epitheliumW)  (H&E ×400). (B) A photomicrograph of a section in a control rat’s kid-
ey showing normal tubules lined with simple cuboidal epithelium (C)
H&E ×400).
ince lead exposure is a well-known stimulant of ROS
roduction and it induces a reduction in free radical scav-
nging enzymes and glutathione [25]. Also, Khan et al.
ound that lead exposed workers showed a signiﬁcantly
ncreased serum MDA  levels over control which indicated
n involvement of oxidative stress in the pathogenesis of
ead toxicity [26]. In addition, the current work proved
 strong correlation between kidney lead level and anti-
xidant parameters (GPX and MDA) which was reported
reviously by Ergurhan-Ilhan et al. [27].
The kidney is particularly susceptible to the lead-
nduced oxidative stress and inﬂammation due to high
oncentration and the relatively long residence time of
ead in the renal tubular epithelial cells [28]. In the cur-
ent study, the lead-treated group of animals (V) showed
isorganization of the glomeruli with sloughing of the
pithelium and widening of Bowman’s space. The glomeru-
ar epithelium showed vaculation and some glomeruli
howed shrinkage. There was inﬂammatory inﬁltration in
he renal medulla. These data are in accordance with Deveci
t al. who reported that chronic lead toxicity induced
arying degree of damaged glomeruli and degenerated
roximal tubules conﬁrming that lead causes tubulo-
nterstitial nephritis [29]. The congestion, inﬂammatory
nﬁltration and atrophied glomeruli in lead acetate treated
ats were also reported by Sujatha et al. who explained
hese histopathological changes by the binding of lead(V)  with shrinked glomerulus (S) (H&E ×400). (C) A photomicrograph
of  a section in the renal cortex of a lead treated rat (group V) showing
inﬂammatory inﬁltration (F) (H&E ×400).
to sulfhydryl groups of essential enzymes of cellular
metabolism [30].
Despite the reported effects of lead exposure on kid-
ney lead level, anti-oxidant parameters and histopathology
of the kidney, there was no signiﬁcant effect on the kid-
ney function tests in accordance with Missoun et al. [31].
Meanwhile, Karamala et al. reported signiﬁcant increase in
serum creatinine in a dose dependent manner due to higher
dose used resulting in severe renal parenchymal damage
with impaired glomerular ﬁltration [32].
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Fig. 4. (A) A photomicrograph of a section in the renal cortex of lead, gar-
lic  and silymarin treated group (VI) showing shrinkage of one glomerulus
with disappearance of Bowman’s space (S) with appearance of normal
glomeruli (G) and tubules (T) (H&E ×400). (B) A photomicrograph of a
section in the renal cortex of lead, garlic and silymarin treated group (VI)
Fig. 5. (A) A photomicrograph of a section in the renal cortex of lead and
DMSA treated group (VII) showing normal glomerulus (G) with slight con-
gestion and widening of Bowman’s capsule of another glomerulus (W)  and
normal tubules (T) (H&E ×400). (B) A photomicrograph of a section in the
renal medulla of Lead & DMSA treated group (VII) showing normal tubulesshowing normal tubules lined by simple cuboidal epithelium (C) with
slight inﬂammatory inﬁltration (F) (H&E ×400).
In the present study, treatment of lead intoxicated rats
with garlic combined to silymarin resulted in a signiﬁ-
cant decrease in kidney lead level, partial recovery in GPX
level and complete improvement in MDA  level. Recov-
ery of some glomeruli and decrease in the congestion and
inﬂammatory inﬁltration in the medulla was also detected.
Senapati et al. reported that the efﬁciency of garlic in reduc-
ing kidney lead level was perhaps due to the presence
of sulfur-containing compounds. These compounds might
have chelated Pb and enhanced its excretion from the body,
resulting in reduced Pb accumulation in tissues and blood.
In the current study, sulfur containing compounds like
allyl trisulphide, trisulphide methyl 2-propenyl, diallyl di
and tetrasulphide and disulphide methyl 1 propenylwere
actually detected by GC-MS analysis of garlic extract [33].
Shakiba et al. reported that prevention of Pb toxicity by
garlic organo-sulfur compounds can be explained by their
ability in scavenging of free radical and prevention of GSH
depletion [34].with normal simple cuboidal epithelium (C) with minimal inﬂammatory
inﬁltration (F) (H&E ×400).
Allicin is a major component of garlic organo-sulfur and
its antioxidant properties has been conﬁrmed by many
investigations [35]. However, in the current work, the
allicin was  not detected by GC–MS analysis because allicin
itself is an unstable compound and instantly undergoes
reactions to form other sulfur derivatives. The presence
of disulﬁdes and trisulﬁdes conﬁrms the degradation of
allicin [36]. In addition to allicin; other garlic organosulfur
compounds, like allyl-triisulﬁde, also possess antioxi-
dant properties and can neutralize several types of ROS
[37].
Silymarin can result in elevation of glutathione levels
through the maintenance of GSH homeostasis in the body
[11]. The sulfhydryl group of glutathione can bind lead
[38].
In this work, treatment with DMSA in lead intoxicated
rats resulted in a signiﬁcant reduction in kidney lead level,
reversal of both GPX and MDA  to the control levels and
improvement in the histopathological changes in the form
of recovery of some glomeruli and decrease in the conges-
tion and inﬂammatory inﬁltration in the medulla. DMSA is
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 dithiol (containing two sulfhydryl, or S–H, groups) lipid-
oluble compound, used for metal chelation. One of the
ulfhydryls in DMSA binds to a cysteine residue on albu-
in, leaving the other S–H available to chelate metals [39].
MSA for being an antioxidant and a strong lead chelator
as been shown to deplete signiﬁcantly lead from tissues
ncluding kidney [13], and recovery in the oxidative stress
40]. Khalil-Manesh et al. reported that DMSA can improve
he renal function and to a lesser degree the pathological
lterations induced by lead toxicity. DMSA can improve
enal function irrespective of the degree of pathological
lterations concluding that the DMSA effect is most likely
ediated by hemodynamic changes [41]. Fortunately, in
he current study the effect of garlic combined to sily-
arin in improvement of lead induced nephropathy was
omparable to the effect of DMSA, as evidenced by the non-
igniﬁcant difference between them in all the measured
arameters of the study.
. Conclusion
It can be concluded that combined garlic extract and
ilymarin as well as DMSA can decrease kidney lead level.
lso, garlic and silymarin were effective in recovering the
evel of antioxidant enzymes. But DMSA was more effective
n elevating GPX level. Lead causes various histopathologi-
al lesions that could be improved by both garlic combined
ith silymarin and DMSA.
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